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Adolescence is the critical time for developing proper oligodendrocyte (OL)-neuron
interaction and the peak of onset for many cognitive diseases, among which anxiety
disorders display the highest prevalence. However, whether impairment of de novo
OL development causes neuronal abnormalities and contributes to the early onset of
anxiety phenotype in childhood still remains unexplored. In this study, we tested the
hypothesis that defects in OL maturation manifests cortical neuron function and leads
to anxiety-like behaviors in juvenile mice. We report here that conditional knockout
of the Olig2 gene (Olig2 cKO) specifically in differentiating OLs in the mouse brain
preferentially impaired OL maturation in the gray matter of cerebral cortex. Interestingly,
localized proton magnetic resonance spectroscopy revealed that Olig2 cKO mice
displayed abnormally elevated cortical glutamate levels. In addition, transmission
electron microscopy demonstrated increased vesicle density in excitatory glutamatergic
synapses in the cortex of the Olig2 cKO mice. Moreover, juvenile Olig2 cKO mice
exhibited anxiety-like behaviors and impairment in behavioral inhibition. Taken together,
our results suggest that impaired OL development affects glutamatergic neuron function
in the cortex and causes anxiety-related behaviors in juvenile mice. These discoveries
raise an intriguing possibility that OL defects may be a contributing mechanism for the
onset of anxiety in childhood.
Keywords: oligodendrocyte, brain development, Olig2 knockout, cortical neurons, glutamate, anxiety behavior
INTRODUCTION
Adolescence is a peak time for the onset of numerous mental disorders, represented by anxiety,
impulse control disorders, and schizophrenia (Paus et al., 2008). One in ﬁve children and
adolescents suﬀers from a mental illness that persists into adulthood. Among the numerous
mental disorders, the prevalence of anxiety is the highest (Kessler et al., 2005). Consistent with
the emotionality, risk-taking and impulsivity characters (Butters, 2011), anxiety phenotypes often
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begin in childhood and early adolescence, sometimes continue
into the adulthood (Lee et al., 2014). However, molecular and
cellular mechanisms that lead to anxiety in adolescence remain
unknown, which is a prevailing issue in understanding the early
onset of mental dysfunction.
In the adolescent brain, the structure of neuronal circuits
and the functional properties of neurons are highly plastic (Tau
and Peterson, 2010). Not only the number and morphology
of synapses are dynamically altered (Penzes et al., 2011), the
availability of neurotransmitters and corresponding receptors
also undergo diﬀerential regulation in various brain regions
(Lee et al., 2014). Conceivably, a transient interference of
neurotransmission may markedly aﬀect the functional balance
of neuronal circuitry in the young brain, thus resulting in
dysregulated emotions and actions (Casey et al., 2008). Moreover,
recent clinical studies revealed that aberrantly elevated glutamate
levels in the anterior cingulate cortex were positively correlated
with clinical symptoms of anxiety and impulsivity in patients
(Phan et al., 2005; Hoerst et al., 2010; Modi et al., 2014). These
ﬁndings suggest that abnormal cortical glutamate homeostasis
may contribute to the pathogenesis of anxiety disorders, while the
underlying mechanisms remain undeﬁned.
Synaptic transmission and cognitive ability are tightly
regulated by neuron-glia interaction (de Hoz and Simons, 2015).
Emerging evidence suggests key roles of oligodendroglia (OL)
in brain function and psychiatric diseases (Fields, 2008). In
particular, the clinical onset of anxiety peaks during vigorous
OL and myelin development in the cerebral cortex (Kessler
et al., 2005; Miller et al., 2012; Young et al., 2013). Besides the
classical view of OL function in myelination that is essential
for saltatory conductance, recent studies revealed that OL also
provides trophic factors and metabolites that are critical for
modulating neuronal function and plasticity (Du and Dreyfus,
2002; Funfschilling et al., 2012; Lee et al., 2012). In fact,
essential role of OL is demonstrated in higher brain function,
including learning motor skills, long distance connectivity and
spiking-timing-dependent plasticity (McKenzie et al., 2014; Nave
and Ehrenreich, 2014). Moreover, OL impairment is frequently
observed in neuropsychiatric disorders, including schizophrenia,
bipolar, and major depression (Fields, 2008; Edgar and Sibille,
2012; Cassoli et al., 2015). Nonetheless, whether defects in OL
development during childhood and early adolescence may aﬀect
cortical neurons and contribute to the anxiety behaviors still
remain unexplored.
In this study, we explored whether speciﬁc impairment of de
novo OL maturation may aﬀect cortical glutamate and result in
maladaptive behaviors in juvenile mice. The Olig2 gene encodes
a transcription factor essential for OL lineage speciﬁcation,
diﬀerentiation and myelination (Zhou et al., 2000; Lu et al.,
2002; Ligon et al., 2006; Yue et al., 2006; Mei et al., 2013). We
showed that conditional deletion of the Olig2 gene speciﬁcally
in diﬀerentiated OLs resulted in preferential reduction of mature
OL in the cerebral cortex. Interestingly, Olig2 cKO mice display
abnormally elevated glutamate levels in the cortex and increased
density of vesicles in cortical glutamatergic synapses in young
mice. Moreover, juvenile Olig2 cKO mice showed anxiety and
impulsivity-like behaviors. Taking together, our results indicate
that impaired OL development in the cortex interferes with
glutamate function and lead to anxiety- and impulsivity-like
behaviors reminiscent of adolescent mental illnesses.
MATERIALS AND METHODS
Animals
The Olig2-ﬂox mice were previously described (Yue et al., 2006)
in which the Olig2 coding region is ﬂanked by two inserted
loxp sites. The mice that express Cre recombinase under the
control of the CNPase (CNP) promoter (CNP-Cre mice) were
also previously described (Lappe-Siefke et al., 2003) where Cre
recombinase was knocked into one allele of the CNP gene locus.
To delete Olig2 in oligodendroglia lineage cells, Olig2loxp/loxp
mice were crossed with the CNP-Cre+/− mice to generate both
CNP-Cre+; Olig2loxp/loxp oﬀspring (Olig2 cKO) and CNP-Cre−;
Olig2loxp/loxp littermates (WT).
Ethics Statement
All animal experiments were performed according to an
approved protocol from the Laboratory Animal Welfare and
Ethics Committee of the Third Military Medical University.
Immunohistochemistry
At the age of postnatal day 21 (P21), mice (n = 6 for each
group) were deeply anesthetized with 1% sodium pentobarbital
and transcardially perfused with 4% paraformaldehyde in
PBS. Brains were dehydrated in 10, 20, 30% sucrose in 4%
paraformaldehyde for 12 h, respectively. The frozen brains were
sectioned (20 μm) on a cryostat microtome (MS 1900, Leica).
Free-ﬂoating sections were incubated with primary antibodies
overnight at 4◦C after blocking with PBS containing 0.3%
TritonX-100 and 5% bovine serum at 37◦C for 1 h. Then they
were incubated with secondary antibodies for 3 h following by
SABC regent (1:200; VECTASTAIN) for 1h at room temperature.
The antigen-antibody complexes were visualized using DAB
(Boster) as the chromogen. The primary antibodies included:
mouse anti-CC1 (1:500; Millipore), rabbit anti-PDGFRα (1:200;
Santa Cruz Biotechnology). Biotinylated secondary antibodies to
rabbit (1:1000; VECTOR BA1000) or mouse (1:1000; VECTOR
BA9200) were used as indicated in the legends.
Western Blotting
At the age of P21, mice (n = 7 in WT, n = 8 in Olig2 cKO) were
anesthetized with 1% pentobarbital. Cerebral cortex (anterior
cingulated area) and corpus callosum were rapidly removed
and frozen. Frozen samples were homogenized and proteins
were extracted using RIPA lyses buﬀer with protease inhibitors
(Roche). Lysates containing 40 μg protein were denatured in gel-
loading buﬀer, separated on 10% SDS-PAGE gels, transferred to
PVDF membranes and visualized by chemiluminescence (ECL
plus, GE Healthcare). Quantiﬁcation of band intensity was
analyzed using Image-Pro Plus software 5.0 (Media Cybernetics).
The following primary antibodies were used: mouse anti-
Olig2 (1:500; Millipore), mouse anti-MBP (1:1000; Santa Cruz
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Biotechnology) and mouse anti-β-actin (1:2000; Santa Cruz
Biotechnology).
MRI and MRS
At the age of P21, MRI and MRS were performed, as recently
described (Michaelis et al., 2009), on Olig2 cKO (n = 7)
and WT control (n = 6). Mice were initially anesthetized
with 5% isoﬂurane, subsequently incubated and kept under
anesthesia with 1.75% isoﬂurane in ambient air. In vivo localized
proton MRS (PRESS, TR/TE = 3,000/20 ms) in cerebral
cortex (2.5 mm × 1 mm × 2.5 mm) was performed at 7.0T
(Bruker BioSpec 70/20 USR). T2-weighted MRI (Turbo-RARE,
TR/TE = 1,500/35ms, 8 echoes, slice thickness 500 μm) in axial
and sagittal orientation served to ensure a proper position of
volumes-of-interest. Metabolite quantiﬁcation involved spectral
evaluation by LCModel and calibration with brain water
concentration (Provencher, 1993). Metabolites with Cramer-Rao
lower bounds above 20% were excluded from further analyses.
Quantification of Glutamate in Cerebral
Cortex
At the age of P21, mice (n = 6 for each group) were initially
anesthetized with 5% isoﬂurane. Cerebral cortex (anterior
cingulate area) was removed and frozen at −80◦C immediately.
The brain tissues were homogenized with 100 μl glutamate
assay buﬀer and followed the manufacturer’s instruction from
Glutamate assay kit (Sigma). The 10KD spin ﬁlters (Biovision)
were applied. The absorbance was measured at 450 nm with
Model 680 microplate reader (Bio-Rad).
Electron Microscopy
Electron microscopy (EM) analysis was performed as previously
described (Mei et al., 2013). At the age of P21, mice were
initially anesthetized with 5% isoﬂurane. The anterior cingulate
cortex of Olig2 cKO mice (n = 3) and WT controls (n = 3)
were removed rapidly and ﬁxed in fresh ﬁxative overnight at
4◦C. Tissue cubes (1 mm × 1 mm × 1 mm) were rinsed in
PBS, postﬁxed in 1% OsO4 in PBS for 2 h, counterstained with
uranyl acetate, dehydrated in a graded ethanol series, inﬁltrated
with propylene oxide, and embedded in Epon. Ultrathin sections
(∼60 nm) were generated by an ultramicrotome (LKB-V, LKB
Produkter AB, Bromma) and were viewed with a transmission
electron microscope (TECNAI10, Philips). Three sections from
each mouse were investigated at a comparable location from
Olig2 cKO and WT control mice under magniﬁcation of 60k.
Digital images were acquired with an AMT XR-60 CCD Digital
Camera System and analyzed using Image-Pro Plus software 5.0
(Media Cybernetics).
Behavioral Tests
Olig2 cKO mice and WT littermates were housed in a controlled
environment (25◦C) with free access to food and water and
maintained on a 12 h/12 h day/night cycle. Behavioral tests were
conducted on sex-balanced groups of experimentally naive mice
at P21. All tests were done from 10:00 h to 18:00 h. One group of
mice were tested in open-ﬁeld test (between 10:00 h and 12:00 h)
and elevated plus-maze test (between 15:00 h and 18:00 h) on the
same day to measure anxiety. Another group of mice were only
tested in cliﬀ avoidance reaction (CAR) test (between 10:00 h
and 18:00 h) to measure impulsivity. After each experiment, all
the apparatuses were wiped clean with 70% ethanol to prevent
a bias due to olfactory cues. For all behavioral experiments,
investigators were blinded for genotype and mice were gently
handled to avoid stress.
Open ﬁeld test was performed using an open-ﬁeld activity
system (Biowill, Shanghai, China), as described (Wang et al.,
2013). Brieﬂy, mice (n = 26 in WT, n = 18 in Olig2
cKO) were placed in the center of the open-ﬁeld box
(50 cm × 50 cm × 50 cm), and activity was recorded during a
period of 10 min. The total and center-area travel distances were
measured and the time spent in the central area was recorded.
Elevated plus-maze test was conducted as previously described
(Katayama et al., 2010). Brieﬂy, mice (n = 24 in WT, n = 15
in Olig2 cKO) were tested on a plus-maze apparatus (Biowill,
Shanghai, China) [closed arms, 25 × 5 × 15 (H) cm; open arms
25 × 5 × 0.3 (H) cm] arranged orthogonally 60 cm above the
ﬂoor. Each mouse was initially placed in the center area facing an
open arm, and then allowed to move freely in the maze for 5 min.
The total travel distance on the maze, time spent on any arms and
entries into any arms were recorded.
Cliﬀ avoidance reaction test was conducted as previously
described with slight modiﬁcation (Yamashita et al., 2013). Mice
(n = 14 inWT, n = 15 inOlig2 cKO) were assessed using a round
platform (diameter, 16 cm; height, 50 cm). The test was initiated
by gently placing an animal on the platform with the forelimbs
approached the edge. If the animal fell from the platform during
the 20 min test, it was judged to have impaired CAR. The
latency from an initial placement on the platform until falling
was recorded. The incidence of impaired CAR was calculated as
a percentage index for each group: % (CAR) = (the number of
intact CARmice (which did not fall from platform)/total number
of tested mice) × 100. Duration of each entry into the edge area,
which was deﬁned as an outer ring with a width of 2 cm, was
recorded before the mouse fell oﬀ.
Statistical Analysis
Weperformed statistical analyses using the SPSS software version
13.0. All the data were conﬁrmed to be normal distribution,
as tested by the Kolmogorov–Smirnov test. For between-group
comparisons, we used the Independent-Samples t-test with
Welch correction, if the variance was unequal. We considered
results to be signiﬁcant at p< 0.05.
RESULTS
The Loss of Olig2 Preferentially Impaired
OL Maturation in the Cerebral Cortex
To explore the consequence of impaired OL development on
brain function, conditional deletion of the Olig2 gene was
achieved in diﬀerentiated OL during neonatal development
by introducing expression of the cre recombinase under
transcriptional control of the CNPase promoter (CNP-Cre) in
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the Olig2-loxp mice (Figure 1A). The oﬀspring were genotyped
by PCR at postnatal day 7 (P7) to identify Olig2loxp/loxp mice
that carry the CNP-Cre allele (Olig2 cKO) and Olig2loxp/loxp
littermates that lack theCNP-Cre allele (WT control) (Figure 1B).
The knockout eﬃciency of Olig2 was conﬁrmed by the
diminished expression of the Olig2 protein in both the corpus
callosum and cerebral cortex of the Olig2 cKO mice at P21
(Figure 1C). To investigate the eﬀects of Olig2 loss on OL
development, we quantiﬁed oligodendroglia progenitor cells
(OPCs) marked by immunohistochemistry staining of PDGF
receptor α (PDGFRα) and mature OL marked by CC1. As shown
in Figure 2, the numbers of CC1+ mature OL in Olig2 cKO mice
were signiﬁcantly decreased by 85.6% in the cortex (250 ± 13
in WT vs. 36 ± 2.8 in Olig2 cKO) and 36.1% (521 ± 40 in WT
vs. 333 ± 47 in Olig2 cKO) in the corpus callosum, respectively
(Figures 2A,B). In contrast, the density of PDGFRα+ OPCs
was not aﬀected (Figures 2C,D). These results suggest that OL
maturation is preferentially aﬀected in the cerebral cortex of
the Olig2 cKO. Such a conclusion is further supported by the
observation that myelin basic protein (MBP) was reduced 94%
in the Olig2 cKO cortex (100 ± 12.3% in WT vs. 6.6 ± 3.0%
in Olig2 cKO), but only reduced 60% in the Olig2 cKO corpus
callosum (100 ± 15.1% in WT vs. 40.0 ± 7.3% in Olig2 cKO)
(Figures 2E,F).
The Cerebral Cortex of Olig2 cKO Mice
Harbored Abnormally Higher Levels of
Glutamate
To explore whether and how impaired OL maturation may
interfere with neuronal function in the juvenile brain, we
examined the spectrum of neurochemicals in the cortex of
WT and Olig2 cKO mice at the age of P21 using proton
magnetic resonance spectroscopy (1H MRS). T2-weighted MRI
images in axial and sagittal orientation were used to ensure the
volume-of-interest (Figure 3A). Representative MRS spectrums
showed resonance of various neurochemicals (Figure 3B).
N-acetylaspartate (NAA) and glutamate (Glu) are the two most
abundant neurochemicals in the brain. The peak areas for NAA
and Glu were normalized to that of creatine (Cr) for quantitative
comparison between the genotypes. Interestingly, the Olig2 cKO
cortex harbors a moderate yet statistically signiﬁcant increase of
Glu/Cr than WT littermates (0.83 ± 0.02 in WT vs. 0.93 ± 0.03
in Olig2 cKO, P = 0.01) (Figure 3D). In contrast, the ratio
of NAA/Cr, which is thought to reﬂect neuronal health or
viability (Urenjak et al., 1993), was not altered in the Olig2
cKO mutant (P = 0.379) (Figure 3C). In addition, choline
(Cho) level showed a trend of decrease in the Olig2 cKO
cortex, although no statistical signiﬁcance was achieved (data
not shown). The increase of glutamate in Olig2 cKO cortex
was further validated by enzymatic assay, in which a signiﬁcant
increase of total glutamate in the cortex of Olig2 cKO mice was
observed (1.32 ± 0.06 μg/mg in WT vs. 1.53 ± 0.06 μg/mg in
Olig2 cKO, P = 0.029) (Figure 3E). These results demonstrated
that impaired OL maturation speciﬁcally leads to an abnormal
increase of glutamate in the cortex without altering neuronal
viability.
Glutamatergic Synapses of Olig2 cKO
Cortical Neurons Contained Higher
Density of Synaptic Vehicles
Glutamate is the primary excitatory neurotransmitter, which is
largely stored in synaptic vesicles in pyramidal neurons and
released upon synaptic stimulation in the cortex (Fonnum,
1984). The long axonal projections of cortical glutamatergic
neurons are the primary target for myelination (Tomassy et al.,
2014). Moreover, most non-myelinating cortical OLs form
contacts with the soma of glutamatergic neurons (Takasaki
et al., 2010). Thus, we next questioned whether OL impairment
caused by the loss of Olig2 may aﬀect glutamatergic synapses.
Transmission EM images were captured in randomly selected
FIGURE 1 | Generating Olig2 conditional knockout mice. (A) Diagram shows Olig2flox/flox mice were crossed with mice that express Cre recombinase under the
control of the CNPase promoter to generate Olig2 cKO mice. (B) The offspring were genotyped by PCR for cnp-cre and floxed Olig2 alleles. (C) Western Blot
analyses showed an absence of Olig2 protein in cortex and corpus callosum of Olig2 cKO mice.
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FIGURE 2 | Preferential impairment of oligodendroglia maturation in the cortex of Olig2 cKO mice. (A) Representative images of immunohistochemistry of
CC1 showing mature oligodendrocytes (OLs) (white arrow head) in the cortex and corpus callosum from WT and Olig2 cKO mice. (B) Quantification of the density of
CC1+ cells in the cortex and corpus callosum from WT and Olig2 cKO mice. (C) Representative images of immunohistochemistry of PDGFRα+ showing
oligodendroglia progenitor cells (OPCs) in the cortex and corpus callosum from WT and Olig2 cKO mice. (D) Quantification of the density of PDGFRα+ cells in the
cortex and corpus callosum from WT and Olig2 cKO mice. (E) Representative Western blot of MBP expression in the cortex and corpus callosum from WT or Olig2
cKO mice. (F) Quantification of MBP signal on the immunoblot of the cortex and corpus callosum from WT or Olig2 cKO mice normalized to β-actin as a loading
control. Scale bars = 100 μm. Data are presented as mean ± SEM. ns, no significant different; ∗P < 0.05; ∗∗P < 0.01.
sections and subjected to double blind analysis. The vesicles
in each asymmetric synapse with a prominent postsynaptic
density (PSD), which is a hall mark of excitatory glutamatergic
synapses, were counted in all EM images. Consistent with
the increase of overall glutamate levels in the cortex of Olig2
cKO mice (Figure 3), the density of synaptic vesicles within
the excitatory presynaptic boutons in the cotex of Olig2 cKO
mice was signiﬁcantly increased as compared to WT controls
(97.2 ± 4.1 in WT vs. 125.2 ± 4.5 in Olig2 cKO) (Figures 4A,B).
We also observed a trend of increase in the numbers of docked
vesicles at the active zone of Olig2 cKO boutons (1.53 ± 0.18 in
WT vs. 1.97 ± 0.18 in Olig2 cKO, P = 0.096) (Figure 4C). No
signiﬁcant diﬀerence was detected in the length of PSD between
WT and Olig2 cKO (282.5 ± 17.7 in WT vs. 260.2 ± 12.5 in
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FIGURE 3 | Aberrantly increased glutamate level in the cortex of Olig2 cKO mice. (A) Representative axial and sagittal T2-weighted MR images indicate the
position and orientation of point-resolved spectroscopy voxel in the cortex (white rectangle). (B) Localized proton magnetic resonance spectra of the cortex from WT
or Olig2 cKO mice, respectively. NAA, N-acetylaspartate; Glu, Glutamate; Cr, total creatine; ppm, parts per million. (C) Quantification of the ratio of NAA/Cr in the
cortex of WT or Olig2 cKO mice. (D) Quantification of the ratio of Glu/Cr in the cortex of WT or Olig2 cKO mice. (E) Quantification of glutamate concentration in the
cortex by the enzymatic assay from WT or Olig2 cKO mice. Data are mean ± SEM. ns, no significant difference. ∗P < 0.05.
Olig2 cKO, P = 0.293) (Figure 4D). These results suggest that
OL impairment caused by the loss ofOlig2may lead to aberrantly
increased glutamate vesicles within synapses and likely increased
glutamate release upon synaptic activation.
Olig2 cKO Mice Displayed Anxiety-like
Behaviors and Deficits in Behavioral
Inhibition
We next tested whether OL impairment and glutamate
abnormalities may lead to maladaptive behaviors in juvenile
mice. We ﬁrst chose the open ﬁeld test and elevated plus maze
test, which are non-conditioned procedures commonly used
for assessing anxiety-like behaviors in rodents (Bourin et al.,
2007). In the open ﬁeld test, juvenile Olig2 cKO mice showed a
signiﬁcantly lower ratio of travel distance within central area to
total travel distance, as compared with WT controls (13.8± 1.2%
in WT vs. 9.0 ± 0.8% in Olig2 cKO, P = 0.004) (Figure 5A)
and spent more time in the central area (30.8 ± 3.6 sec in WT
vs. 51.1 ± 4.1 sec in Olig2 cKO, P = 0.001) (Figure 5B) during
the 10-min test, indicating an anxious phenotype. In addition,
in the elevated plus maze test, the numbers of entry into the
open arms and time spent on the open arms were previously
shown to be inversely related with the anxiety level (Xu et al.,
2014), hence used to identify anxiety-like behaviors (Brunner
et al., 2014). The time spent on the open arms and entries into
the open arms were expressed as a percentage of the total time on
any arms and entries into any arms during the test. We found
that Olig2 cKO mice showed less entries into the open arms
(51.9 ± 2.0% in WT vs. 43.4 ± 3.1% in Olig2 cKO, P = 0.021)
(Figure 5C) and spent less time on open arms (34.1 ± 3.2% in
WT vs. 22.2 ± 2.3% in Olig2 cKO, P = 0.011) (Figure 5D), again
indicating a more anxious behavior. We also assessed locomotor
activity of the animals on the maze by the total distance traveled
on both open and closed arms. We found that Olig2 cKO
mice traveled a signiﬁcantly longer distance than WT controls
(6663 ± 404.5 cm in WT vs. 8264 ± 444.3 cm in Olig2 cKO,
P = 0.014) (Figure 5E), suggesting a higher locomotor activity
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FIGURE 4 | Electronmicrocopy analysis of glutamatergic synapses and synaptic vesicles in the cortex of WT and Olig2 cKO mice. (A) Representative
electron microscopy micrographs show an excitatory synapse in the WT and Olig2 cKO cortices. White arrows indicate docked vesicles. (B) Quantification of the
density of synaptic vesicles in cortical glutamatergic presynaptic boutons from EM images of WT or Olig2 cKO mice. (C) Quantification of the number of docked
vesicles per active zone in WT or Olig2 cKO excitatory synapses. (D) Quantification of the length of the postsynaptic density (PSD) in WT or Olig2 cKO excitatory
synapses. Scale bar = 200 nm, Data are given as mean ± SEM, ∗∗P < 0.01.
FIGURE 5 | Anxiety-like behavior tests on WT and Olig2 cKO mice. Open field test (A,B): Graphs showed ratio of central to total distance (A) and center time
(B) in WT and Olig2 cKO mice. Elevated plus maze test (C–E): Graphs showed number of entries into open arms (C), time spent on the open arms (D) and total
distance traveled on the arms (E), Data are given as mean ± SEM. ∗P < 0.05, ∗∗P < 0.01.
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FIGURE 6 | Impulsivity-like behavior analyses on WT and Olig2 cKO mice. Cliff avoidance reaction test (A–C): an example of the travel pathway of WT and
Olig2 cKO on the elevated platform (A). Olig2 cKO mice failed to avoid the cliff actively by spending significantly more time around the cliff (B). Graphs represent the
time course of CAR measurement in WT and Olig2 cKO mice (C). Data are given as mean ± SEM. ∗∗P < 0.01.
of Olig2 cKO mice on the maze. Together, all the aforementioned
behavior tests consistently demonstrated anxiety-like behaviors
in juvenile Olig2 cKO mice.
Impulsivity is deﬁned as a failure in controlling and inhibiting
the emotion for appropriate actions and behaviors (Dalley
et al., 2008), which is also a typical tendency in adolescence.
Recent studies suggest that certain types of functional impulsivity
may be linked with anxiety (Taylor et al., 2008). Thus, we
explored whether the loss of Olig2 may also lead to impulsivity-
like behavior in juvenile mice. CAR impairment is thought
to represent impulsivity-like behaviors in rodents (Matsuoka
et al., 2005). Unlike many classical mouse impulsivity tests that
require lengthy training, the CAR test can be readily applied to
juvenile mice.We foundOlig2 cKOmice traveledmore and spent
longer time than WT control in the edge area in the CAR test
(17.7 ± 3.1 s in WT vs. 49.4 ± 10.2 s in Olig2 cKO, P = 0.007)
(Figures 6A,B). Moreover, 60% ofOlig2 cKOmice failed to avoid
a potential fall from a height, whereas only 14.3% of WT controls
fell (Figure 6C).These results suggest that the defects in OL
maturation due to the loss of Olig2 also lead to impulsivity-like
behaviors.
DISCUSSION
Using the Olig2 cKO mouse model, our studies demonstrated
that impaired OL maturation can aﬀect glutamate levels in the
cerebral cortex and synaptic vesicle density in glutamatergic
presynaptic boutons. Furthermore, Olig2 cKO mice display
anxiety-relatedmaladaptive behaviors. To our knowledge, it is the
ﬁrst evidence that demonstrates behavioral abnormalities ofOlig2
cKO mice. These results suggests that OL-neuron interaction in
the cortex plays important roles in governing synaptic function
and raises an intriguing possibility that impaired de novo OL
maturation in adolescence may contribute to the early onset of
anxiety.
Proton magnetic resonance spectroscopy (1H MRS) is a non-
invasive technique that provides great advantages in studying
biochemical concentrations of neurotransmitters in vivo (Soares
and Law, 2009). Speciﬁcally, glutamate, which is measured by
1H MRS, has been suggested as an index of cortical excitability
(Stagg et al., 2009, 2011). In multiple clinical MRS studies,
increased cortical glutamate levels were positively correlated
with anxiety symptoms in patients (Phan et al., 2005; Modi
et al., 2014). These observations suggest that hyperfunction of
cortical glutamatergic neurons may be an important contributing
factor for the etiology of anxiety and related disorders.
Extensive studies have demonstrated that a wide variety of
molecular and cellular mechanisms in neurons and nearby
glia cells tightly control glutamate homeostasis and synaptic
release (Deitmer et al., 2003; DeSilva et al., 2009). However,
which mechanism(s) is dysregulated that underlie the increased
glutamate in the cortex of anxiety disorder patients still remains
elusive.
Cortical OL maturation occurs concurrently with the most
frequent onset of anxiety disorders (Kessler et al., 2005; Miller
et al., 2012; Young et al., 2013). In addition, OL and myelin
development overlaps with the time for peak binding of
cortical glutamate to NMDA receptors in early adolescence
(Kornhuber et al., 1988). Therefore, we explored whether
selective impairment of OL maturation may aﬀect glutamatergic
neurons and behavior in juvenile mice. The CNP-Cre mouse line
was used in previous studies for speciﬁc deletion of genes in
mature OL (Wahl et al., 2014; Zou et al., 2014). We employed this
mouse line for conditionally deleting the Olig2 gene that encodes
a transcription factor critical for OL development (Zhou et al.,
2000; Lu et al., 2002; Ligon et al., 2006; Yue et al., 2006; Mei
et al., 2013). Interestingly, Olig2 cKO mice displayed preferential
reduction of cortical mature OLs at P21, whereas OLs in
the corpus callosum were much less severely aﬀected. Hence,
despite the undeﬁned mechanism that underlies the preferential
impairment of OL maturation in the cortex of Olig2 cKO mouse,
this genetic model provides a reasonable tool for dissecting the
role of OL maturation in modulating cortical neuronal function
during juvenile age. Importantly, using 1H MRS, we detected
an overall increase of glutamate in the cortex of Olig2 cKO
mice, suggesting elevated cortical excitability. In addition, we
detected increased vesicles in glutamatergic synapses, which
further supported glutamatergic hyperfunction as a result of
defects in OL maturation. Moreover, juvenile Olig2 cKO mice
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displayed anxiety-related behaviors. Together, these observations
suggest that normal OL development plays essential roles
in governing glutamate signaling and adolescence behavior,
and defects in de novo OL maturation in early postnatal
life could cause aberrant glutamate function and maladaptive
behaviors.
Oligodendroglia impairment may aﬀect cortical neurons
through multiple distinct mechanisms that still remain
elusive. Because the loss of Olig2 could aﬀect myelination
and axonal conductance (Baumann and Pham-Dinh, 2001),
neurons in Olig2 cKO cortex may increase synaptic vesicles
as a compensatory adaptation. This may especially aﬀect
glutamatergic neurons, because their axons are mostly
myelinated by OLs (Tomassy et al., 2014). However,
several lines of evidence argue that myelination defects
alone do not necessarily cause glutamatergic hyperfunction.
For instance, cortical glutamate levels were maintained
normal in the heterozygous shiverer mutant mouse that
lacked one copy of the MBP gene thus displaying
hypomyelination without aﬀecting mature OL density
(Takanashi et al., 2014). Thus, the preferential impairment
of de novo OL maturation in the cortex may be a speciﬁc
mechanism that underlies the aberrant increase of cortical
glutamate.
Unlike white matter OLs that perform primary roles in
myelin formation, cortical OLs display a radial gradient
distribution and diﬀerentially myelinate the long-range
projections of glutamatergic pyramidal neurons in distinct
cortical layers (Tomassy et al., 2014). Besides myelination,
the majority of mature OLs reside in deep layers of cerebral
cortex are attached with the soma of pyramidal neurons,
rather than GABAergic neurons (Takasaki et al., 2010).
Although the function of these perineuronal OLs in the
cortex still remains unknown, accumulating evidence suggest
that OLs can provide metabolic and neurotrophic support
(Du and Dreyfus, 2002). In addition, OLs are known to
express several glutamate transporters (Domercq et al., 1999;
Karadottir et al., 2005), and can uptake glutamate in the
gray matter of the developing brain (DeSilva et al., 2009).
More importantly, cortical perineuronal oligodendroglia,
but not white matter oligodendroglia, express glutamine
synthetase (GS) for converting glutamate to glutamine
(Damelio et al., 1990). It is well established that glutamine
produced by astrocyte GS from the up-taken glutamate
can be recycled into neurons, which plays key roles in
controlling glutamate recycling (Deitmer et al., 2003). In this
regard, cortical gray matter OLs may play important roles
in controlling glutamate homeostasis, in parallel with the
known function of astrocytes in modulating glutamatergic
function.
It is also important to note that besides aberrant glutamate,
abnormalities in other neurotransmitters, including GABA,
dopamine, serotonin and norepinephrine, are also thought
to contribute to anxiety (Kent et al., 2002). Because our
understanding of the functional interplay between OLs and
neurons is still at its infancy, the types of neurons aﬀected by
OL defects still remain undeﬁned. It is conceivable that OL
defects in Olig2 cKO mice could also aﬀect the function of
other neuronal cell types in addition to glutamatergic pyramidal
neurons, which could contribute to the anxiety-like behaviors we
observed in this study. In fact, dopamine transporter knockout
mice are severely impaired in CAR test (Yamashita et al., 2013).
In addition, disturbing neuregulin-1-ErbB4 signaling in OLs
can also lead to increased dopamine receptors and transporters
and anxiety-like behaviors in mice (Roy et al., 2007). Whether
and how OL maturation may modulate dopaminergic function
is a challenging question for future studies. Moreover, the
symptoms of anxiety are shared by some other psychiatric
disorders, like schizophrenia (Buckley et al., 2009), suggesting
that the anxiety like behavior found in Olig2 cKO mice may also
contribute to other psychiatric disorders. In fact, ErbB signaling
pathway has been considered as a potential therapeutic target for
schizophrenia (Deng et al., 2013), which conceivably modulates
OL function. However, many well-established behavioral tests
for cognitive abnormalities require lengthy training hence could
not be applied to juvenile mice. This limits our ability in
the current study that aims to identify juvenile abnormalities
caused by defects of OL maturation. Future studies may need
more speciﬁc behavior tests utilized in both young and adult
mice to explore whether OL maturation aﬀects higher cognitive
function.
CONCLUSION
Our studies demonstrate that impaired OL maturation by
conditional deleting the Olig2 gene in diﬀerentiated OL can
aberrantly increase cortical glutamate, which likely leads to
glutamatergic hyperfunction. Moreover, the defects in de
novo OL maturation clearly result in anxiety-like behaviors
and deﬁcits of behavioral inhibition in juvenile mice. Our
ﬁndings prompt future studies to investigate the intriguing
possibility whether defects in OL and/or myelin development
in childhood may contribute to the pathogenesis of anxiety in
humans.
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